The table below shows BIOGEN INC.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$9.89B
$9.68B
$9.84B
$10.17B
$10.98B
$13.44B
Cost of revenue
$2.40B
$2.31B
$2.53B
$2.28B
$2.11B
$1.81B
Gross profit
-
-
-
-
-
$11.64B
R&D
-
-
-
-
-
-
SG&A
BIIB annual revenue (10-K history)
BIOGEN INC. reported annual revenue of $9.89B for fiscal year 2025. That is up 2.2% from $9.68B in fiscal 2024. Over the 10 fiscal years shown, annual revenue declined from $11.45B (FY 2016) to $9.89B. Figures come from the company's audited annual reports as filed with the SEC.
